Collegeville, PA, United States of America

Ronald K Raby, Jr

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald K Raby, Jr.

Introduction

Ronald K Raby, Jr. is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 6 patents. His work focuses on developing novel polymeric compositions that enhance the delivery of pharmaceutical dosage forms.

Latest Patents

Among his latest patents, Ronald has developed innovative pharmaceutical formulations. One of his inventions is directed to novel pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms. These formulations comprise a plurality of drug substance-containing sub-units, which include capsule compartments and/or solid sub-units. The solid matrix of a polymer contains a drug substance, and the sub-units are connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

Career Highlights

Throughout his career, Ronald has worked with prominent companies in the pharmaceutical industry, including Capsugel Belgium NV and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and contribute to advancements in drug delivery systems.

Collaborations

Ronald has collaborated with several professionals in his field, including Stephen Mark McAllister and Adrian Brown. These collaborations have further enriched his work and have led to innovative solutions in pharmaceutical technology.

Conclusion

Ronald K Raby, Jr. is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact on the industry. His innovative patents and collaborations highlight his commitment to advancing drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…